Ixekizumab for Psoriatic Arthritis: Safety, Efficacy, and Patient Selection
John Miller,1,2 Abin P Puravath,1 Ana-Maria Orbai1,3 1Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 2Lyme Disease Research Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 3Psoriatic Arthritis Program, Johns Hopkins University Scho...
Main Authors: | Miller J, Puravath AP, Orbai AM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-12-01
|
Series: | Journal of Inflammation Research |
Subjects: | |
Online Access: | https://www.dovepress.com/ixekizumab-for-psoriatic-arthritis-safety-efficacy-and-patient-selecti-peer-reviewed-fulltext-article-JIR |
Similar Items
-
Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1)
by: Hideto Kameda, et al.
Published: (2023-10-01) -
Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis
by: Dafna D. Gladman, et al.
Published: (2019-01-01) -
Treatment Retention and Safety of Ixekizumab in Psoriatic Arthritis: A Real Life Single-Center Experience
by: Ignacio Braña, et al.
Published: (2023-01-01) -
A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
by: Bruce W. Kirkham, et al.
Published: (2023-07-01) -
Efficacy and safety of netakimab in patients with psoriatic arthritis: results of the phase III PATERA clinical study
by: T. V. Korotaeva, et al.
Published: (2020-11-01)